BridgeMD
New treatment option for GERD
Official title Heartburn, Gastroesophageal Reflux Disease
ClinicalTrials.gov ID: NCT07268820
What this study is testing
What is Zastaprazan?
Zastaprazan is an investigational medicine, given as an once-daily, being studied as a potential treatment for gerd.
Also referred to as P-CAB.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Gastroesophageal reflux disease (GERD) is a condition caused by the reflux of stomach contents into the esophagus, presenting with typical symptoms such as heartburn and acid regurgitation. GERD is a chronic condition that affects quality of life, and patients with this condition are known to have a lower quality of life compared to healthy individuals.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Korean adults aged 19 years or older as of the date of written consent
- Those diagnosed with erosive gastroesophageal reflux disease based on upper gastrointestinal endoscopy (EGD)
- Those who reported nighttime heartburn for more than 3 months at the time of screening (Visit 1)
- Those who voluntarily decided to participate and provide written informed consent
You likely can't join if
- Those who cannot undergo upper gastrointestinal endoscopy (EGD)
- Individuals with a history of drug or alcohol abuse (within the past year)
- Individuals who have received other investigational products within one month prior to the screening visit (Visit 1)
- In addition to the above, individuals with clinically significant findings that the investigator deems medically inappropriate for the present study
The study team makes the final eligibility decision.
Where it's taking place
- Ansan, South Korea
- Busan, South Korea
- Chilgok, South Korea
- Chuncheon, South Korea
- Gwangju, South Korea
- Incheon, South Korea
- Seoul, South Korea
- Yangsan, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ansan, South Korea; Busan, South Korea; Chilgok, South Korea; Chuncheon, South Korea; Gwangju, South Korea; Incheon, South Korea and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.